47.19 USD
↘ 1.47 (3.02%)AT CLOSE (11:59 AM EDT)
Novo-Nordisk A/S
NVONYSE • USD
47.26
↗ 0.07 (0.16%)
POST MARKET (AS OF 07:58 PM EDT)
Post Market
AS OF 07:58 PM EDT
47.26
↗ 0.07 (0.16%)
Market: CLOSED
NVO is currently priced at $47.25. The technical outlook is "Buy" based on moving average alignment, RSI, and MACD signals. Notable factors include a bullish Golden Cross on the moving averages.
Technical & fundamental data as of Aug 26, 2026.
Open?$47.80
High?$48.04
Low?$46.87
Prev. Close?$48.66
Volume?8.9M
Avg. Volume?N/A
VWAP?$47.39
Bid / Ask
Bid?$47.18 × 500
Ask?$47.35 × 100
Spread?$0.17
Midpoint?$47.27
Valuation & Ratios
Market Cap?215.1B
Shares Out?3.4B
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients with diabetes, as well as injectable and oral GLP-1 therapies, across its obesity and diabetes care segment. Novo also has a rare disease segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Themes
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestLow
Short Interest?33.8M
Days to Cover?2.2
Avg Daily Volume15.5M
Settlement Date2026-08-14